[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100592174":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":25,"centralContacts":29,"locations":24,"responsibleParty":35,"collaborators":24,"id":37,"slug":38,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":41,"acronym":42,"eligibilityCriteria":43,"healthyVolunteers":44,"sex":45,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":24,"studyType":51,"phases":52,"briefSummary":54,"conditions":55,"keywords":58,"overallStatus":62,"whyStopped":24,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":24},{"fullName":5,"class":6},"Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients with Ocular Disease","EXPERIMENTAL","Holodoppler Imaging, Acquisition of useable video images",[13],"Device: Images Acquisition",{"label":15,"type":16,"description":11,"interventionNames":17},"participants without Ocular Disease","ACTIVE_COMPARATOR",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DEVICE","Images Acquisition","Acquisition of useable video images",[9,15],null,[26],{"name":27,"affiliation":5,"role":28},"Michel PAQUES","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":24,"email":34},"Nabil BROUK","CONTACT","00 33 1 40 02 11 44","nbrouk@15-20.fr",{"type":36,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100592174","study-of-human-ocular-hemodynamics-by-holography-dopple-100592174",false,"NCT06989996","Study of Human Ocular Hemodynamics by Holography Dopple","HoLoEye","Inclusion Criteria:\n\nCriteria common to both populations ( patients and healthy volunteers) :\n\n* Age ≥ 18 years and \\\u003C 75 years;\n* Having received informed information about the study and having signed a consent to participate in the study;\n* Affiliated or covered by social security\n\nCriteria for healthy volunteers :\n\nNo ocular or systemic disease deemed to affect ocular circulation by an investigator\n\nSpecific criteria for patients:\n\n* Subjects usually followed at one of the recruiting centers;\n* Patients with chronic glaucoma, for whom a therapeutic modification is planned in the short term;\n* Patients with carotid stenosis;\n* Patients with choroidal pathology: pachychoroidism having led to pigment epithelium anomalies.\n\nExclusion Criteria:\n\n* For all participants:\n* Persons covered by articles L1121-5 to L1121-8 of the CSP (all protected persons: pregnant women, parturients, nursing mothers, persons deprived of their liberty by judicial decision or administrative decision, minors, and persons under legal protection: guardianship or curatorship);\n* Women of childbearing age not using an effective method of contraception, or positive pregnancy test (blood or urine);\n* Participants allergic to tropicamide when using pupillary dilatation;\n* Inability of the subject to maintain a stable sitting position for research procedures;\n* Temporary contraindication to HoloDoppler:\n\n  * Patient suffering from viral conjunctivitis or any other infectious disease;\n  * Patient with skin lesions on the neck or forehead, for which contact with a chin strap is not recommended.\n* Impossibility of making acquisitions of interest (e.g. due to a pupil diameter that is too small, advanced cataracts, nystagmus, etc.).\n* Wearing glasses or contact lenses to correct a refractive disorder is not considered a criterion for non-inclusion.",true,"ALL","18 Years","74 Years",{"count":49,"type":50},148,"ESTIMATED","INTERVENTIONAL",[53],"NA","Prospective, interventional, non-randomized, open-label study, multi-center, Gehan-designed study with sequential inclusions in each subgroup, ranging from 4 subjects to a maximum 37 subjects per subgroup included",[56,57],"Glaucoma","Retinal Vascular Disorder",[59,60,61],"glaucoma","pachychoroid,","carotid stenosis","NOT_YET_RECRUITING","2025-05-16",{"date":65,"type":66},"2025-05-25","ACTUAL",{"date":68,"type":50},"2025-06",{"date":70,"type":50},"2028-06",{"name":5,"class":6}]